BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 9622629)

  • 1. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury.
    Porreca F; Tang QB; Bian D; Riedl M; Elde R; Lai J
    Brain Res; 1998 Jun; 795(1-2):197-203. PubMed ID: 9622629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats.
    Chen SR; Pan HL
    Anesthesiology; 2003 Dec; 99(6):1409-14. PubMed ID: 14639157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons.
    Budai D; Fields HL
    J Neurophysiol; 1998 Feb; 79(2):677-87. PubMed ID: 9463431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mu-Opioid receptor-mediated reduction of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-activated current in dorsal horn neurons.
    Kolaj M; Randic M
    Neurosci Lett; 1996 Feb; 204(1-2):133-7. PubMed ID: 8929996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and G-protein coupling of mu-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats.
    Ballet S; Conrath M; Fischer J; Kaneko T; Hamon M; Cesselin F
    Neuropeptides; 2003 Aug; 37(4):211-9. PubMed ID: 12906839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of melanocortin-induced changes in spinal nociception by mu-opioid receptor agonist and antagonist in neuropathic rats.
    Starowicz K; Przewlocki R; Gispen WH; Przewlocka B
    Neuroreport; 2002 Dec; 13(18):2447-52. PubMed ID: 12499847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
    Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
    J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury.
    Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F
    Neurosci Lett; 1995 Oct; 199(2):83-6. PubMed ID: 8584249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
    Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
    Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic intrathecal morphine administration produces homologous mu receptor/G-protein desensitization specifically in spinal cord.
    Maher CE; Eisenach JC; Pan HL; Xiao R; Childers SR
    Brain Res; 2001 Mar; 895(1-2):1-8. PubMed ID: 11259753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays.
    Márki A; Monory K; Otvös F; Tóth G; Krassnig R; Schmidhammer H; Traynor JR; Roques BP; Maldonado R; Borsodi A
    Eur J Pharmacol; 1999 Oct; 383(2):209-14. PubMed ID: 10585536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.